Synthesis of a versatile metacyclophane macrolactam

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Oncology

Background:

• Heat shock protein 90 (Hsp90) is a crucial molecular chaperone implicated in cancer progression.
• Hsp90 inhibitors are a promising avenue for cancer chemotherapy development.
• Natural products like geldanamycin and radicicol are known Hsp90 inhibitors, but require structural optimization.

Purpose of the Study:

• To synthesize novel chimeric Hsp90 inhibitors by combining structural features of geldanamycin and radicicol.
• To develop a versatile synthetic approach for creating diverse functionalized inhibitors.
• To elucidate structure-activity relationships (SAR) between these novel compounds and Hsp90.

Main Methods:

• A chimera approach combining quinone and resorcinol moieties of geldanamycin and radicicol, respectively.
• Development of a highly diversifiable alpha-bromo-alpha,beta-unsaturated ester intermediate.
• Synthesis and optimization of chimeric inhibitors for Hsp90 inhibition.

Main Results:

• Successfully produced chimeric molecules exhibiting potent inhibition of Hsp90.
• The novel synthetic intermediate facilitates the introduction of diverse functionalities.
• The strategy enables systematic exploration of SAR for Hsp90-targeted cancer therapeutics.

Conclusions:

• The developed chimeric inhibitors represent a promising class of Hsp90-targeting cancer chemotherapeutics.
• The versatile synthetic strategy overcomes limitations in modifying macrolactam structures.
• This work provides a foundation for designing optimized Hsp90 inhibitors with improved efficacy.